Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)

SHA:605177 Revenue

Zhejiang East Asia Pharmaceutical had revenue of 264.57M CNY in the quarter ending March 31, 2026, with 38.58% growth. This brings the company's revenue in the last twelve months to 1.01B, down -2.19% year-over-year. In the year 2025, Zhejiang East Asia Pharmaceutical had annual revenue of 940.19M, down -21.54%.

• Revenue (ttm): 1.01B
• Revenue Growth: -2.19%
• P/S Ratio: 2.51
• Revenue / Employee: 669.64K
• Employees: 1,514
• Market Cap: 2.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	940.19M	-258.05M	-21.54%
Dec 31, 2024	1.20B	-158.21M	-11.66%
Dec 31, 2023	1.36B	176.89M	15.00%
Dec 31, 2022	1.18B	467.34M	65.62%
Dec 31, 2021	712.22M	-169.45M	-19.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error